DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,082,000 | -44.5% | 152,900 | +2.7% | 0.00% | -33.3% |
| Q2 2021 | $5,557,000 | +49.1% | 148,900 | +2.2% | 0.00% | +50.0% |
| Q1 2021 | $3,726,000 | +18.2% | 145,700 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $3,152,000 | +23.0% | 143,100 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $2,562,000 | -27.9% | 142,400 | +1.8% | 0.00% | -33.3% |
| Q2 2020 | $3,553,000 | +94.4% | 139,900 | +40.6% | 0.00% | +50.0% |
| Q1 2020 | $1,828,000 | -15.4% | 99,500 | +1.4% | 0.00% | 0.0% |
| Q4 2019 | $2,161,000 | +56.5% | 98,100 | +2.0% | 0.00% | +100.0% |
| Q3 2019 | $1,381,000 | +0.1% | 96,200 | +9.8% | 0.00% | 0.0% |
| Q2 2019 | $1,380,000 | +17.7% | 87,600 | +9.5% | 0.00% | 0.0% |
| Q1 2019 | $1,172,000 | +45.2% | 80,000 | +6.0% | 0.00% | 0.0% |
| Q4 2018 | $807,000 | -19.3% | 75,500 | +15.3% | 0.00% | 0.0% |
| Q3 2018 | $1,000,000 | +50.8% | 65,500 | +21.1% | 0.00% | 0.0% |
| Q2 2018 | $663,000 | – | 54,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |